HCW Biologics (HCWB) Competitors $8.65 -0.53 (-5.72%) As of 10:15 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock HCWB vs. PLUR, ONCY, ELYM, RVPH, ACRV, ALGS, ESLA, ATHE, FBLG, and OSTXShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include Pluri (PLUR), Oncolytics Biotech (ONCY), Eliem Therapeutics (ELYM), Reviva Pharmaceuticals (RVPH), Acrivon Therapeutics (ACRV), Aligos Therapeutics (ALGS), Estrella Immunopharma (ESLA), Alterity Therapeutics (ATHE), FibroBiologics (FBLG), and OS Therapies (OSTX). These companies are all part of the "pharmaceutical products" industry. HCW Biologics vs. Pluri Oncolytics Biotech Eliem Therapeutics Reviva Pharmaceuticals Acrivon Therapeutics Aligos Therapeutics Estrella Immunopharma Alterity Therapeutics FibroBiologics OS Therapies HCW Biologics (NASDAQ:HCWB) and Pluri (NASDAQ:PLUR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, community ranking, valuation, media sentiment, institutional ownership, risk, earnings and dividends. Does the media prefer HCWB or PLUR? In the previous week, HCW Biologics had 6 more articles in the media than Pluri. MarketBeat recorded 9 mentions for HCW Biologics and 3 mentions for Pluri. HCW Biologics' average media sentiment score of 0.18 beat Pluri's score of 0.07 indicating that HCW Biologics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HCW Biologics 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Pluri 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, HCWB or PLUR? HCW Biologics has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Pluri has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Is HCWB or PLUR more profitable? HCW Biologics has a net margin of -1,067.82% compared to Pluri's net margin of -3,551.49%. HCW Biologics' return on equity of -2,516.84% beat Pluri's return on equity.Company Net Margins Return on Equity Return on Assets HCW Biologics-1,067.82% -2,516.84% -132.95% Pluri -3,551.49%-2,778.13%-83.61% Which has preferable earnings & valuation, HCWB or PLUR? Pluri has lower revenue, but higher earnings than HCW Biologics. Pluri is trading at a lower price-to-earnings ratio than HCW Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHCW Biologics$1.45M9.14-$24.99M-$23.25-0.39Pluri$1.03M36.89-$20.89M-$5.53-0.88 Do institutionals and insiders hold more shares of HCWB or PLUR? 3.0% of HCW Biologics shares are owned by institutional investors. Comparatively, 16.6% of Pluri shares are owned by institutional investors. 49.9% of HCW Biologics shares are owned by company insiders. Comparatively, 10.2% of Pluri shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community believe in HCWB or PLUR? HCW Biologics received 6 more outperform votes than Pluri when rated by MarketBeat users. CompanyUnderperformOutperformHCW BiologicsOutperform Votes6100.00% Underperform VotesNo VotesPluriN/AN/A SummaryHCW Biologics beats Pluri on 8 of the 14 factors compared between the two stocks. Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.33M$6.54B$5.43B$8.48BDividend YieldN/A2.66%5.22%4.11%P/E Ratio-9.189.1426.7920.05Price / Sales9.14255.59395.67116.44Price / CashN/A65.8538.2534.62Price / Book24.816.546.864.61Net Income-$24.99M$143.51M$3.22B$248.19M7 Day Performance4.20%5.60%6.80%2.97%1 Month Performance18.15%10.06%13.69%16.58%1 Year Performance-79.32%-0.86%18.25%8.16% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics1.5386 of 5 stars$8.66-5.7%N/A-79.3%$12.53M$1.45M-8.7040Earnings ReportGap DownPLURPluri0.375 of 5 stars$4.95-5.0%N/A-19.5%$38.47M$678,000.00-0.88150Gap UpONCYOncolytics Biotech1.7698 of 5 stars$0.44-4.9%$4.33+874.7%-61.6%$38.42MN/A-1.6530Earnings ReportAnalyst ForecastGap DownELYMEliem TherapeuticsN/A$1.29+7.5%N/A-84.5%$38.38MN/A-2.439RVPHReviva Pharmaceuticals3.4818 of 5 stars$0.89+8.5%$10.00+1,023.6%-32.5%$38.33MN/A-0.805News CoverageEarnings ReportAnalyst ForecastGap DownACRVAcrivon Therapeutics3.2338 of 5 stars$1.18+2.6%$17.71+1,401.2%-85.4%$37.00MN/A-0.4458Analyst RevisionHigh Trading VolumeALGSAligos Therapeutics3.4841 of 5 stars$5.89+0.9%$70.00+1,088.5%-63.9%$36.01M$3.27M-0.4490ESLAEstrella Immunopharma1.5212 of 5 stars$0.99+2.7%$16.00+1,524.4%-6.7%$35.62MN/A-3.79N/AGap UpATHEAlterity Therapeutics2.0051 of 5 stars$4.05+1.5%$12.00+196.3%+114.3%$35.38MN/A0.0010Gap DownFBLGFibroBiologics1.5852 of 5 stars$0.91-2.5%$13.00+1,327.2%-91.7%$34.85MN/A-4.3410Gap DownOSTXOS Therapies1.7829 of 5 stars$1.59-3.0%$18.00+1,032.1%N/A$34.45MN/A-1.85N/AGap Down Related Companies and Tools Related Companies Pluri Competitors Oncolytics Biotech Competitors Eliem Therapeutics Competitors Reviva Pharmaceuticals Competitors Acrivon Therapeutics Competitors Aligos Therapeutics Competitors Estrella Immunopharma Competitors Alterity Therapeutics Competitors FibroBiologics Competitors OS Therapies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCWB) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
